Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.
“Vecuronium is a nondepolarising neuromuscular blocking agent possessing all of the characteristic pharmacological actions of this class of drugs (curariform). It acts by competing for cholinergic receptors at the motor endplate.”
“The plasma clearance of vecuronium amounts to 3.0 to 5.6 kg -1 .minute -1 and its plasma elimination half-life is 36 to 117 minutes.”
Working under the parallel aged-care framework? Aged-care equivalent →